Adenosquamous Carcinoma of the Pancreas: Outcomes of a Multicenter European Study (ADESQUPAN Project)

Key Points

• Survival rates for patients undergoing surgery for adenosquamous carcinoma are very low, with only 10% surviving five years.
• Patients undergoing T4 tumor resections have particularly poor outcomes, especially those with significant comorbidities.
• Adjuvant chemotherapy is recommended after resection, but is often not given due to severe postoperative complications.
• The findings emphasize the need for careful patient selection and risk assessment prior to surgical intervention.